NET PROFIT (x1000 NOK)
EMPLOYEES
Aranda Pharma Oy
Closing information (x1000 NOK)
| Closing information | 2016/12 | ||
| Earnings before taxes | -2,435 | ||
| Total assets | 4,625 | ||
| Current assets | 3,553 | ||
| Current liabilities | 327 | ||
| Equity capital | 3,117 | ||
| - share capital | 27 | ||
| Employees (average) | 2 |
Financial ratios
| Fiscal year | 2016/12 | ||
| Solvency | 67.4% | ||
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio | 1086.5% | ||
| Return on equity (ROE) | -78.1% | ||
| Change turnover | |||
| Change turnover % | |||
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2016/12 | ||
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.